TG THERAPEUTICS, INC. (TGTX) /
The profitability of TG THERAPEUTICS, INC. over the past 10 years
Chart TG THERAPEUTICS, INC.: gross profit, operating income, net income, fiscal 2016–2025 Open the chart →TG THERAPEUTICS, INC. reported net income of $447.18M in fiscal 2025, the latest fiscal year on file. That year it had gross profit of $515.57M and operating income of $123.32M. It reported a profit in 3 of the 10 years shown, and a loss in fiscal 2016, 2017, 2018, 2019, 2020, 2021 and 2022.
Year by year
| Fiscal year | Gross profit | Operating income | Net income |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $515.57M* | $123.32M | $447.18M |
| 2024ended Dec 31, 2024 | $290.52M* | $41.93M | $23.38M |
| 2023ended Dec 31, 2023 | $219.53M* | $20.63M | $12.67M |
| 2022ended Dec 31, 2022 | $2.52M* | -$218.32M | -$223.81M |
| 2021ended Dec 31, 2021 | $5.9M* | -$344.77M | -$348.1M |
| 2020ended Dec 31, 2020 | — | -$273.59M | -$279.38M |
| 2019ended Dec 31, 2019 | — | -$169.06M | -$172.87M |
| 2018ended Dec 31, 2018 | — | -$174.4M | -$173.48M |
| 2017ended Dec 31, 2017 | — | -$118.71M | -$118.48M |
| 2016ended Dec 31, 2016 | — | -$78.97M | -$78.25M |
Fiscal years as TG THERAPEUTICS, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on TG THERAPEUTICS, INC.
- The revenue of TG THERAPEUTICS, INC.
- The cash flow of TG THERAPEUTICS, INC.
- The debt of TG THERAPEUTICS, INC.
- All of TG THERAPEUTICS, INC.'s financials, charted
Companies of a similar size
- PRIPrimerica, Inc.
- VMIValmont Industries, Inc.
- SANMSanmina Corporation
- AOSA. O. Smith Corporation
- MORNMORNINGSTAR, INC.
Not investment advice. This page shows what TG THERAPEUTICS, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.